Intellia Therapeutics (NTLA) Net Shares Issued and Repurchased (2016 - 2026)
Powered by 
Analysis
Intellia Therapeutics (NTLA) Net Shares Issued and Repurchased (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Intellia Therapeutics | 1.70 Bn | 1.70 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 731,481.00 |
| Dec 31, 2025 | 935,063.00 |
| Mar 31, 2025 | 640,751.00 |
| Dec 31, 2024 | 918,161.00 |
| Mar 31, 2024 | 680,804.00 |
| Dec 31, 2023 | 569,821.00 |
| Mar 31, 2023 | 513,605.00 |
| Dec 31, 2022 | 391,910.00 |
| Mar 31, 2022 | 319,680.00 |
| Dec 31, 2021 | 2.73 Mn |
| Mar 31, 2021 | 1.65 Mn |
| Dec 31, 2020 | 2.98 Mn |
| Mar 31, 2020 | 2.10 Mn |
| Dec 31, 2019 | 1.22 Mn |
| Mar 31, 2019 | 446,333.00 |
| Dec 31, 2018 | 2.13 Mn |
| Mar 31, 2018 | 792,414.00 |
| Dec 31, 2017 | 2.69 Mn |
| Mar 31, 2017 | 1.34 Mn |
| Dec 31, 2016 | 2.61 Mn |